[HTML][HTML] Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases

Y Wang, J Hu, S Wu, JS Fleishman, Y Li, Y Xu… - … and Targeted Therapy, 2023 - nature.com
Ferroptosis, a unique modality of cell death with mechanistic and morphological differences
from other cell death modes, plays a pivotal role in regulating tumorigenesis and offers a …

[HTML][HTML] Alzheimer's disease: Novel targets and investigational drugs for disease modification

JL Cummings, AML Osse, JW Kinney - Drugs, 2023 - Springer
Novel agents addressing non-amyloid, non-tau targets in Alzheimer's Disease (AD)
comprise 70% of the AD drug development pipeline of agents currently in clinical trials. Most …

[HTML][HTML] Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson's disease

Y Wang, S Wu, Q Li, W Lang, W Li, X Jiang… - Frontiers in …, 2022 - frontiersin.org
Epigallocatechin 3-gallate (EGCG), an abundant polyphenolic component derived from
green tea extract, possesses versatile bioactivities that can combat many diseases. During …

Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments

MY Zamanian, RMR Parra, A Soltani… - Molecular Biology …, 2023 - Springer
Parkinson's disease (PD) as a prevalent neurodegenerative condition impairs motor function
and is caused by the progressive deterioration of nigrostriatal dopaminergic (DAergic) …

Carbon monoxide signaling: examining its engagement with various molecular targets in the context of binding affinity, concentration, and biologic response

Z Yuan, LK De La Cruz, X Yang, B Wang - Pharmacological Reviews, 2022 - ASPET
Carbon monoxide (CO) has been firmly established as an endogenous signaling molecule
with a variety of pathophysiological and pharmacological functions, including …

[HTML][HTML] Neuroinflammation in Parkinson's disease: from gene to clinic: a systematic review

C Castillo-Rangel, G Marin… - International Journal of …, 2023 - mdpi.com
Parkinson's disease is a neurodegenerative disease whose progression and clinical
characteristics have a close bidirectional and multilevel relationship with the process of …

Antioxidant therapy against TGF‐β/SMAD pathway involved in organ fibrosis

S Ghafouri‐Fard, A Askari, H Shoorei… - Journal of Cellular …, 2024 - Wiley Online Library
Fibrosis refers to excessive build‐up of scar tissue and extracellular matrix components in
different organs. In recent years, it has been revealed that different cytokines and …

[HTML][HTML] Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory …

L Fornari Laurindo, J Aparecido Dias… - Frontiers in …, 2024 - frontiersin.org
The increasing life expectancy has led to a higher incidence of age-related
neurodegenerative conditions. Within this framework, neuroinflammation emerges as a …

[HTML][HTML] The neuroprotective effects and therapeutic potential of the chalcone cardamonin for Alzheimer's disease

K Barber, P Mendonca, KFA Soliman - Brain Sciences, 2023 - mdpi.com
Neurodegenerative diseases (ND) include a wide range of conditions that result from
progressive damage to the neurons. Alzheimer's disease (AD) is one of the most common …

Geniposide protects against neurotoxicity in mouse models of rotenone-induced Parkinson's disease involving the mTOR and Nrf2 pathways

Q Zhou, B Chen, Y Xu, Y Wang, Z He, X Cai… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance Fructus Gardeniae, with the effects of discharging
fire, eliminating vexation, reducing fever and causing diuresis, and cooling blood to remove …